Breaking News Headlines Today | Ground News

See every side of every news story

Pharmaceutical-technology.com image

News from pharmaceutical-technology.com

Ground News rates Pharmaceutical-technology.com’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, AllSides, and Media Bias/Fact Check.

Pharmaceutical-technology.com’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Pharmaceutical-technology.com

Where is Pharmaceutical-technology.com located?Pharmaceutical-technology.com's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Pharmaceutical-technology.com News

US vaccine advisers say not all babies need a hepatitis B shot at birth — REUTERS / pwu404

Hepatitis B · United States

US vaccine advisers say not all babies need a hepatitis B shot at birth

54% Center coverage: 358 sources

A federal vaccine advisory committee has voted to end a longstanding recommendation that all U.S. babies get the hepatitis B vaccine on the day they’re born.See the Story

Pharmaceutical Giant to Invest $6B in Alabama Facility

GLP-1 · Huntsville

Pharmaceutical Giant to Invest $6B in Alabama Facility

71% Center coverage: 27 sources

Eli Lilly announced plans to construct a $6 billion pharmaceutical manufacturing facility in Huntsville, aiming to enhance medication production control and create 450 jobs.See the Story

Health Canada approves 1st pill to treat postpartum depression — A tender close-up of a pregnant woman's hands holding her belly, symbolizing maternity and love. by Daniel Reche/Pexels / Pexels

Health Canada · Canada

Health Canada approves 1st pill to treat postpartum depression

73% Left coverage: 26 sources

Health Canada has approved the first drug designed to treat postpartum depression.Zuranolone, sold under the brand name Zurzuvae, is a pill taken once a day for 14 days and can start relieving depressive symptoms in as few as three days.Manufactured by Biogen, the drug has been approved for use in the United States since late 2023 and is also authorized in the U.K. and the European Union.See the Story

Blindspots

Hepatitis B Change Endangers Babies

Low coverage from Right Sources

Hepatitis B Change Endangers Babies

Breaking News Topics Related to Pharmaceutical-technology.com